PubRank

R Fijnheer

Author PubWeight™ 52.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999 5.55
2 Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital. Infection 2007 2.35
3 Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. J Thromb Haemost 2003 2.12
4 Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 2000 1.78
5 Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost 2006 1.68
6 von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 1999 1.62
7 Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation. Neth J Med 2001 1.50
8 Antibodies that stop the adrenals in their tracks. Lancet 2001 1.48
9 von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999 1.36
10 Platelet function alterations in dengue are associated with plasma leakage. Thromb Haemost 2014 1.13
11 Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997 1.11
12 Plasma levels of cellular fibronectin in diabetes. Diabetes Care 2001 1.06
13 Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum 2000 1.00
14 VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost 2009 1.00
15 A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood. Hematol Oncol 2006 0.99
16 Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. J Thromb Haemost 2006 0.98
17 Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease. Ann N Y Acad Sci 2002 0.95
18 Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation. Histopathology 2003 0.94
19 Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. J Neurol Neurosurg Psychiatry 2006 0.94
20 Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens 1998 0.89
21 Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996 0.88
22 The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission. J Thromb Haemost 2009 0.86
23 Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 2013 0.86
24 Spinal dural arteriovenous fistulas are not associated with prothrombotic factors. Stroke 2004 0.85
25 Improvement of platelet storage conditions by using new polyolefin containers. Transfusion 1997 0.85
26 Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant 2006 0.85
27 Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus. Clin Exp Immunol 2001 0.83
28 Risk factors for cystoid macular oedema in patients with uveitis. Eye (Lond) 2006 0.83
29 FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura. J Thromb Haemost 2006 0.81
30 Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 2005 0.81
31 Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006 0.80
32 Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers. J Rheumatol 2001 0.79
33 Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus. Br J Ophthalmol 2004 0.79
34 Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia. Br J Haematol 2000 0.79
35 Beneficial effect of pre-transfusion warming of platelets prepared from buffy coats. Lancet 1990 0.79
36 The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting. Transfus Med 2012 0.79
37 Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease. Circulation 1999 0.78
38 Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant 2003 0.78
39 Depletion of dense granule nucleotides during storage of human platelets. Thromb Haemost 1990 0.77
40 Endothelial markers in chronic heart failure: training normalizes exercise-induced vWF release. Eur J Clin Invest 2004 0.77
41 Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy. Neurology 2006 0.76
42 Identification of N-linked glycosylation and putative O-fucosylation, C-mannosylation sites in plasma derived ADAMTS13. J Thromb Haemost 2014 0.76
43 New therapeutic options for immune thrombocytopenia. Neth J Med 2011 0.76
44 No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease. Am J Hematol 2002 0.75
45 Soluble P-selectin in diabetes. Thromb Haemost 1999 0.75
46 Elastase mediated fibrinolysis in acute promyelocytic leukemia. Thromb Haemost 2000 0.75
47 [Aggressive non-Hodgkin lymphoma in 3 patients with rheumatoid arthritis: discontinue the use of methotrexate]. Ned Tijdschr Geneeskd 2008 0.75
48 Activation of hemostasis is associated with early cognitive decline after off-pump coronary artery bypass surgery. J Thromb Haemost 2005 0.75
49 [Acquired von Willebrand syndrome]. Ned Tijdschr Geneeskd 2003 0.75
50 [A woman suffering from systemic lupus erythematosus and acquired thrombotic thrombocytopenic purpura]. Ned Tijdschr Geneeskd 2004 0.75
51 Treatment of primary autoimmune thrombocytopenia (AITP) [1]. Vox Sang 2011 0.75
52 [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura]. Ned Tijdschr Geneeskd 2004 0.75
53 Cyclosporin for thrombotic thrombocytopenic purpura after autologous bone marrow transplantation. Br J Haematol 1997 0.75
54 A case of colonic mantle cell lymphoma: new insights in a rare disease. Endoscopy 2009 0.75
55 An erythropoietin-producing endometrium carcinoma. Eur J Cancer 1994 0.75
56 Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation. Br J Haematol 2001 0.75